Oncology
1 drug is in development for Waldenstrom Macroglobulinemia.
- Companies
- 1
- Clinical trials
- 20
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Waldenstrom Macroglobulinemia pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Sonrotoclax | BeOne Medicines Ltd. (ONC) |
About this indication
Waldenstrom Macroglobulinemia context
Oncology·MeSH: Waldenstrom Macroglobulinemia (D008258)
Also known as: Lymphoma, Lymphocytic, Plasmacytoid, Lymphomas, Lymphoplasmacytoid, Lymphoplasmacytoid Lymphoma, Macroglobulinaemia, Waldenstrom's, Macroglobulinemia, Macroglobulinemia, Primary, Macroglobulinemia, Waldenstrom's, Waldenstrom Macroglobulinaemia
Frequently asked questions
How many drugs are in development for Waldenstrom Macroglobulinemia?
BioSniper tracks 1 drug in development for Waldenstrom Macroglobulinemia across 1 company.
How many clinical trials target Waldenstrom Macroglobulinemia?
There are 20 clinical trials targeting Waldenstrom Macroglobulinemia tracked by BioSniper.